ArticleInfectious diseases and therapy2022

Brand-Specific Enhanced Safety Surveillance Study of GSK's Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season.

Gaël Dos Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.